Neogen (NEOG) Net Cash Flow Growth (1y) (2011 - 2026)
Neogen (NEOG) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 76.43% |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | 198.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 198.35% |
| Nov 30, 2025 | -66.23% |
| Aug 31, 2025 | 118.15% |
| May 31, 2025 | -116.94% |
| Feb 28, 2025 | 72.27% |
| Nov 30, 2024 | -19.50% |
| Aug 31, 2024 | -428.83% |
| May 31, 2024 | -90.68% |
| Feb 29, 2024 | -16.19% |
| Nov 30, 2023 | 640.42% |
| Aug 31, 2023 | -77.50% |
| May 31, 2023 | 4,236.60% |
| Feb 28, 2023 | -395.55% |
| Nov 30, 2022 | 68.69% |
| Aug 31, 2022 | 6,053.00% |
| May 31, 2022 | 125.75% |
| Feb 28, 2022 | 80.67% |
| Nov 30, 2021 | -130.18% |
| Aug 31, 2021 | 79.12% |
| May 31, 2021 | -93.28% |